This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility: Sustainable packaging is only the beginning. What a medicine is made from—and how its ingredients are produced—matters just as much.
Yet the synthesis of compounds for pharmaceutical research can still depend on fossil feedstocks, high temperatures, strong oxidants and metals that raise costs and complicate purification. Two recently published studies from Colmenares' group at IPC PAS demonstrate that cleaner chemistry can begin at the level of a single chemical bond. The studies are published in the journal Ultrasonics Sonochemistry and Chemistry—A European Journal.
At the heart of both studies is lignin, one of nature's most abundant polymers and a major byproduct of wood processing. Instead of simply burning it, chemists can use its aromatic structures as building blocks for more valuable compounds. The teams combined this renewable feedstock with light and ultrasound.
Light activates the catalyst, while inaudible sound waves produce cavitation: microscopic bubbles form and collapse violently. Energy is generated locally, where the chemistry happens, without exposing the whole system to extreme heat. Marta Paszkiewicz-Gawron and colleagues transformed coniferyl alcohol into dehydrodiconiferyl alcohol (DHCA), a compound formed by linking two coniferyl alcohol units.
Under optimized conditions, the reaction achieved 100% substrate conversion and 54% selectivity to DHCA, while remaining stable during a 24-hour test. Acoustic-field mapping showed that ultrasound is not merely a mixing tool: its intensity and distribution can steer the product profile. DHCA has previously been investigated in preclinical studies of wound healing and the regulation of bone-forming cells.
Behdokht Hashemi Hosseini and colleagues created a metal-free catalyst from lignin and chitosan, which is obtained from chitin found in sources such as crustacean shells. It joined two acetovanillone molecules to form diapocynin with more than 97% selectivity and a 33% yield. Diapocynin—the dimer of the NADPH oxidase inhibitor apocynin—is being investigated in disease models for limiting damaging reactive oxygen species.
Extract — continue reading at the source.
